SCHEMBL7107412

SCHEMBL7107412

CSc1nccc(CC(=O)O)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.49
FFAR4 Q5NUL3 1/20 0.47
PARP1 P09874 1/20 0.42
KMT2A Q03164 3/20 0.41
NTRK1 P04629 1/20 0.39
MEN1 O00255 2/20 0.39
GABRA5 P31644 2/20 0.38
GABRB2 P47870 2/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA3 P34903 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRA4 P48169 1/20 0.38
GABRE P78334 1/20 0.38
GABRA6 Q16445 1/20 0.38
GABRG1 Q8N1C3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4672966 0.86 PARP1 (0.42) ALOX15FFAR4PARP1KMT2ANTRK1
SCHEMBL2933353 0.83 RAB9A (0.42) ALOX15FFAR4KMT2ANTRK1MEN1
SCHEMBL2459868 0.82 CYP1A2 (0.48) ALOX15FFAR4PARP1KMT2ANTRK1
SCHEMBL22924834 0.82 KMT2A (0.44) ALOX15FFAR4PARP1KMT2AMEN1
SCHEMBL29751883 0.80 PARP1 (0.41) ALOX15FFAR4PARP1KMT2ANTRK1
SCHEMBL31422596 0.80 KMT2A (0.43) ALOX15FFAR4KMT2AMEN1ALDH1A1
SCHEMBL1725109 0.78 PARP1 (0.43) ALOX15FFAR4PARP1KMT2AMEN1
SCHEMBL30871087 0.77 CTDSP1 (0.51) ALOX15FFAR4PARP1KMT2AMEN1
SCHEMBL4420456 0.77 NPC1 (0.54) KMT2AMEN1ALDH1A1LMNANPC1
SCHEMBL1554048 0.77 RAB9A (0.54) KMT2AALDH1A1LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030158218-A1 Thrombin inhibitors NANTERMET PHILIPPE G (US) 2003-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158218-A1 Thrombin inhibitors F2, SERPINC1, TFPI ALOX15 2095/4885FFAR4 4636/4885PARP1 313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.